Industry Research Reports
Home > Reports > Pharma & Healthcare > Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 102 Pages
Report ld: 3479280
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Conjunctivitis Market Size(US$)
CAGR 2025-2031
1.6%
Market Size,2031
USD 4,099
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,727 million
Market Forecast in 2031(Value)
US$ 4,099 million
CAGR
1.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Conjunctivitis was estimated to be worth US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.
The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.
This report aims to provide a comprehensive presentation of the global market for Conjunctivitis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Conjunctivitis by region & country, by Type, and by End User.
The Conjunctivitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjunctivitis.
MARKET SEGMENTATION
By Company
- Novartis (CH)
- Santen Pharmaceutical (JP)
- Bausch & Lomb (US)
- Allergan (US)
- Sun Pharmaceutical (ID)
- Akorn (US)
- Freda (CN)
- Sinqi (CN)
- Univision (CN)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Antibiotic
- Pills
- Ointment
Segment by Application
- Newborns
- Children
- Adults
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Conjunctivitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Conjunctivitis in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Conjunctivitis Product Introduction
1.2 Global Conjunctivitis Market Size Forecast
1.2.1 Global Conjunctivitis Sales Value (2020-2031)
1.2.2 Global Conjunctivitis Sales Volume (2020-2031)
1.2.3 Global Conjunctivitis Sales Price (2020-2031)
1.3 Conjunctivitis Market Trends & Drivers
1.3.1 Conjunctivitis Industry Trends
1.3.2 Conjunctivitis Market Drivers & Opportunity
1.3.3 Conjunctivitis Market Challenges
1.3.4 Conjunctivitis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Conjunctivitis Players Revenue Ranking (2024)
2.2 Global Conjunctivitis Revenue by Company (2020-2025)
2.3 Global Conjunctivitis Players Sales Volume Ranking (2024)
2.4 Global Conjunctivitis Sales Volume by Company Players (2020-2025)
2.5 Global Conjunctivitis Average Price by Company (2020-2025)
2.6 Key Manufacturers Conjunctivitis Manufacturing Base and Headquarters
2.7 Key Manufacturers Conjunctivitis Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Conjunctivitis
2.9 Conjunctivitis Market Competitive Analysis
2.9.1 Conjunctivitis Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Conjunctivitis Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibiotic
3.1.2 Pills
3.1.3 Ointment
3.2 Global Conjunctivitis Sales Value by Type
3.2.1 Global Conjunctivitis Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Conjunctivitis Sales Value, by Type (2020-2031)
3.2.3 Global Conjunctivitis Sales Value, by Type (%) (2020-2031)
3.3 Global Conjunctivitis Sales Volume by Type
3.3.1 Global Conjunctivitis Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Conjunctivitis Sales Volume, by Type (2020-2031)
3.3.3 Global Conjunctivitis Sales Volume, by Type (%) (2020-2031)
3.4 Global Conjunctivitis Average Price by Type (2020-2031)
4 Segmentation by End User
4.1 Introduction by End User
4.1.1 Newborns
4.1.2 Children
4.1.3 Adults
4.2 Global Conjunctivitis Sales Value by End User
4.2.1 Global Conjunctivitis Sales Value by End User (2020 VS 2024 VS 2031)
4.2.2 Global Conjunctivitis Sales Value, by End User (2020-2031)
4.2.3 Global Conjunctivitis Sales Value, by End User (%) (2020-2031)
4.3 Global Conjunctivitis Sales Volume by End User
4.3.1 Global Conjunctivitis Sales Volume by End User (2020 VS 2024 VS 2031)
4.3.2 Global Conjunctivitis Sales Volume, by End User (2020-2031)
4.3.3 Global Conjunctivitis Sales Volume, by End User (%) (2020-2031)
4.4 Global Conjunctivitis Average Price by End User (2020-2031)
5 Segmentation by Region
5.1 Global Conjunctivitis Sales Value by Region
5.1.1 Global Conjunctivitis Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Conjunctivitis Sales Value by Region (2020-2025)
5.1.3 Global Conjunctivitis Sales Value by Region (2026-2031)
5.1.4 Global Conjunctivitis Sales Value by Region (%), (2020-2031)
5.2 Global Conjunctivitis Sales Volume by Region
5.2.1 Global Conjunctivitis Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Conjunctivitis Sales Volume by Region (2020-2025)
5.2.3 Global Conjunctivitis Sales Volume by Region (2026-2031)
5.2.4 Global Conjunctivitis Sales Volume by Region (%), (2020-2031)
5.3 Global Conjunctivitis Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Conjunctivitis Sales Value, 2020-2031
5.4.2 North America Conjunctivitis Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Conjunctivitis Sales Value, 2020-2031
5.5.2 Europe Conjunctivitis Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Conjunctivitis Sales Value, 2020-2031
5.6.2 Asia Pacific Conjunctivitis Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Conjunctivitis Sales Value, 2020-2031
5.7.2 South America Conjunctivitis Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Conjunctivitis Sales Value, 2020-2031
5.8.2 Middle East & Africa Conjunctivitis Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Conjunctivitis Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Conjunctivitis Sales Value
6.2.1 Key Countries/Regions Conjunctivitis Sales Value, 2020-2031
6.2.2 Key Countries/Regions Conjunctivitis Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Conjunctivitis Sales Value, 2020-2031
6.3.2 United States Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Conjunctivitis Sales Value by End User, 2024 VS 2031
6.4 Europe
6.4.1 Europe Conjunctivitis Sales Value, 2020-2031
6.4.2 Europe Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Conjunctivitis Sales Value by End User, 2024 VS 2031
6.5 China
6.5.1 China Conjunctivitis Sales Value, 2020-2031
6.5.2 China Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.5.3 China Conjunctivitis Sales Value by End User, 2024 VS 2031
6.6 Japan
6.6.1 Japan Conjunctivitis Sales Value, 2020-2031
6.6.2 Japan Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Conjunctivitis Sales Value by End User, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Conjunctivitis Sales Value, 2020-2031
6.7.2 South Korea Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Conjunctivitis Sales Value by End User, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Conjunctivitis Sales Value, 2020-2031
6.8.2 Southeast Asia Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Conjunctivitis Sales Value by End User, 2024 VS 2031
6.9 India
6.9.1 India Conjunctivitis Sales Value, 2020-2031
6.9.2 India Conjunctivitis Sales Value by Type (%), 2024 VS 2031
6.9.3 India Conjunctivitis Sales Value by End User, 2024 VS 2031
7 Company Profiles
7.1 Novartis (CH)
7.1.1 Novartis (CH) Company Information
7.1.2 Novartis (CH) Introduction and Business Overview
7.1.3 Novartis (CH) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Novartis (CH) Conjunctivitis Product Offerings
7.1.5 Novartis (CH) Recent Development
7.2 Santen Pharmaceutical (JP)
7.2.1 Santen Pharmaceutical (JP) Company Information
7.2.2 Santen Pharmaceutical (JP) Introduction and Business Overview
7.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Offerings
7.2.5 Santen Pharmaceutical (JP) Recent Development
7.3 Bausch & Lomb (US)
7.3.1 Bausch & Lomb (US) Company Information
7.3.2 Bausch & Lomb (US) Introduction and Business Overview
7.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bausch & Lomb (US) Conjunctivitis Product Offerings
7.3.5 Bausch & Lomb (US) Recent Development
7.4 Allergan (US)
7.4.1 Allergan (US) Company Information
7.4.2 Allergan (US) Introduction and Business Overview
7.4.3 Allergan (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Allergan (US) Conjunctivitis Product Offerings
7.4.5 Allergan (US) Recent Development
7.5 Sun Pharmaceutical (ID)
7.5.1 Sun Pharmaceutical (ID) Company Information
7.5.2 Sun Pharmaceutical (ID) Introduction and Business Overview
7.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Offerings
7.5.5 Sun Pharmaceutical (ID) Recent Development
7.6 Akorn (US)
7.6.1 Akorn (US) Company Information
7.6.2 Akorn (US) Introduction and Business Overview
7.6.3 Akorn (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Akorn (US) Conjunctivitis Product Offerings
7.6.5 Akorn (US) Recent Development
7.7 Freda (CN)
7.7.1 Freda (CN) Company Information
7.7.2 Freda (CN) Introduction and Business Overview
7.7.3 Freda (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Freda (CN) Conjunctivitis Product Offerings
7.7.5 Freda (CN) Recent Development
7.8 Sinqi (CN)
7.8.1 Sinqi (CN) Company Information
7.8.2 Sinqi (CN) Introduction and Business Overview
7.8.3 Sinqi (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sinqi (CN) Conjunctivitis Product Offerings
7.8.5 Sinqi (CN) Recent Development
7.9 Univision (CN)
7.9.1 Univision (CN) Company Information
7.9.2 Univision (CN) Introduction and Business Overview
7.9.3 Univision (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Univision (CN) Conjunctivitis Product Offerings
7.9.5 Univision (CN) Recent Development
8 Industry Chain Analysis
8.1 Conjunctivitis Industrial Chain
8.2 Conjunctivitis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Conjunctivitis Sales Model
8.5.2 Sales Channel
8.5.3 Conjunctivitis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Conjunctivitis Market Trends
Table 2. Conjunctivitis Market Drivers & Opportunity
Table 3. Conjunctivitis Market Challenges
Table 4. Conjunctivitis Market Restraints
Table 5. Global Conjunctivitis Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Conjunctivitis Revenue Market Share by Company (2020-2025)
Table 7. Global Conjunctivitis Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Conjunctivitis Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Conjunctivitis Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Conjunctivitis Manufacturing Base and Headquarters
Table 11. Key Manufacturers Conjunctivitis Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Conjunctivitis
Table 13. Global Conjunctivitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Conjunctivitis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Conjunctivitis Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Conjunctivitis Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Conjunctivitis Sales Market Share in Value by Type (2020-2025)
Table 20. Global Conjunctivitis Sales Market Share in Value by Type (2026-2031)
Table 21. Global Conjunctivitis Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Conjunctivitis Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Conjunctivitis Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Conjunctivitis Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Conjunctivitis Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Conjunctivitis Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Conjunctivitis Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Conjunctivitis Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Conjunctivitis Sales Value by End User (2020-2025) & (US$ Million)
Table 30. Global Conjunctivitis Sales Value by End User (2026-2031) & (US$ Million)
Table 31. Global Conjunctivitis Sales Market Share in Value by End User (2020-2025)
Table 32. Global Conjunctivitis Sales Market Share in Value by End User (2026-2031)
Table 33. Global Conjunctivitis Sales Volume by End User: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Conjunctivitis Sales Volume by End User (2020-2025) & (K Units)
Table 35. Global Conjunctivitis Sales Volume by End User (2026-2031) & (K Units)
Table 36. Global Conjunctivitis Sales Market Share in Volume by End User (2020-2025)
Table 37. Global Conjunctivitis Sales Market Share in Volume by End User (2026-2031)
Table 38. Global Conjunctivitis Price by End User (2020-2025) & (USD/Unit)
Table 39. Global Conjunctivitis Price by End User (2026-2031) & (USD/Unit)
Table 40. Global Conjunctivitis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Conjunctivitis Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Conjunctivitis Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Conjunctivitis Sales Value by Region (2020-2025) & (%)
Table 44. Global Conjunctivitis Sales Value by Region (2026-2031) & (%)
Table 45. Global Conjunctivitis Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Conjunctivitis Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Conjunctivitis Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Conjunctivitis Sales Volume by Region (2020-2025) & (%)
Table 49. Global Conjunctivitis Sales Volume by Region (2026-2031) & (%)
Table 50. Global Conjunctivitis Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Conjunctivitis Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Conjunctivitis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Conjunctivitis Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Conjunctivitis Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Conjunctivitis Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Conjunctivitis Sales Volume, (2026-2031) & (K Units)
Table 57. Novartis (CH) Company Information
Table 58. Novartis (CH) Introduction and Business Overview
Table 59. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Novartis (CH) Conjunctivitis Product Offerings
Table 61. Novartis (CH) Recent Development
Table 62. Santen Pharmaceutical (JP) Company Information
Table 63. Santen Pharmaceutical (JP) Introduction and Business Overview
Table 64. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Santen Pharmaceutical (JP) Conjunctivitis Product Offerings
Table 66. Santen Pharmaceutical (JP) Recent Development
Table 67. Bausch & Lomb (US) Company Information
Table 68. Bausch & Lomb (US) Introduction and Business Overview
Table 69. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bausch & Lomb (US) Conjunctivitis Product Offerings
Table 71. Bausch & Lomb (US) Recent Development
Table 72. Allergan (US) Company Information
Table 73. Allergan (US) Introduction and Business Overview
Table 74. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Allergan (US) Conjunctivitis Product Offerings
Table 76. Allergan (US) Recent Development
Table 77. Sun Pharmaceutical (ID) Company Information
Table 78. Sun Pharmaceutical (ID) Introduction and Business Overview
Table 79. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Sun Pharmaceutical (ID) Conjunctivitis Product Offerings
Table 81. Sun Pharmaceutical (ID) Recent Development
Table 82. Akorn (US) Company Information
Table 83. Akorn (US) Introduction and Business Overview
Table 84. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Akorn (US) Conjunctivitis Product Offerings
Table 86. Akorn (US) Recent Development
Table 87. Freda (CN) Company Information
Table 88. Freda (CN) Introduction and Business Overview
Table 89. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Freda (CN) Conjunctivitis Product Offerings
Table 91. Freda (CN) Recent Development
Table 92. Sinqi (CN) Company Information
Table 93. Sinqi (CN) Introduction and Business Overview
Table 94. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Sinqi (CN) Conjunctivitis Product Offerings
Table 96. Sinqi (CN) Recent Development
Table 97. Univision (CN) Company Information
Table 98. Univision (CN) Introduction and Business Overview
Table 99. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Univision (CN) Conjunctivitis Product Offerings
Table 101. Univision (CN) Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Conjunctivitis Downstream Customers
Table 105. Conjunctivitis Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Conjunctivitis Product Picture
Figure 2. Global Conjunctivitis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Conjunctivitis Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Conjunctivitis Sales Volume (2020-2031) & (K Units)
Figure 5. Global Conjunctivitis Sales Price (2020-2031) & (USD/Unit)
Figure 6. Conjunctivitis Report Years Considered
Figure 7. Global Conjunctivitis Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Conjunctivitis Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Conjunctivitis Revenue in 2024
Figure 10. Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Antibiotic Picture
Figure 12. Pills Picture
Figure 13. Ointment Picture
Figure 14. Global Conjunctivitis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Conjunctivitis Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Conjunctivitis Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Conjunctivitis Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Conjunctivitis Price by Type (2020-2031) & (USD/Unit)
Figure 19. Product Picture of Newborns
Figure 20. Product Picture of Children
Figure 21. Product Picture of Adults
Figure 22. Global Conjunctivitis Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Conjunctivitis Sales Value Market Share by End User, 2024 & 2031
Figure 24. Global Conjunctivitis Sales Volume by End User (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Conjunctivitis Sales Volume Market Share by End User, 2024 & 2031
Figure 26. Global Conjunctivitis Price by End User (2020-2031) & (USD/Unit)
Figure 27. North America Conjunctivitis Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Conjunctivitis Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Conjunctivitis Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Conjunctivitis Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Conjunctivitis Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Conjunctivitis Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Conjunctivitis Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Conjunctivitis Sales Volume (%), (2020-2031)
Figure 39. United States Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 42. Europe Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 45. China Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 47. China Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 48. Japan Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 51. South Korea Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 54. Southeast Asia Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 57. India Conjunctivitis Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Conjunctivitis Sales Value by Type (%), 2024 VS 2031
Figure 59. India Conjunctivitis Sales Value by End User (%), 2024 VS 2031
Figure 60. Conjunctivitis Industrial Chain
Figure 61. Conjunctivitis Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Conjunctivitis in 2025?
The global market size of Conjunctivitis in 2025 was 3727 Million USD.
What was the global market size of Conjunctivitis in 2031?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Conjunctivitis market size from 2025 to 2031?
Which companies rank high in the global Conjunctivitis market?
Related Reports
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Conjunctivitis market size was US$ 3727 million in 2025 and is forecast to reach a readjusted size of US$ 4158 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
Global Conjunctivitis Market Research Report 2026
The global Conjunctivitis market was valued at US$ 3727 million in 2025 and is anticipated to reach US$ 4158 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Conjunctivitis was estimated to be worth US$ 3727 million in 2025 and is projected to reach US$ 4158 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 3950.00
(Single User License)
Global Conjunctivitis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Conjunctivitis market is projected to grow from US$ 3674 million in 2024 to US$ 4099 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 133
USD 4900.00
(Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Conjunctivitis was estimated to be worth US$ 3674 million and is forecast to reach approximately US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 132
USD 5900.00
(Single User License)
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Conjunctivitis market size was US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 76
USD 4250.00
(Single User License)
Global Conjunctivitis Market Research Report 2025
The global market for Conjunctivitis was valued at US$ 3674 million in the year 2024 and is projected to reach a revised size of US$ 4099 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Global Conjunctivitis Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-16
Pages: 125
USD 5900.00
(Single User License)
Global Conjunctivitis Market Insights, Forecast to 2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-07
Pages: 95
USD 4900.00
(Single User License)
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Conjunctivitis market size was US$ 3727 million in 2025 and is forecast to reach a readjusted size of US$ 4158 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
USD 4250.00 (Single User License)Global Conjunctivitis Market Research Report 2026
The global Conjunctivitis market was valued at US$ 3727 million in 2025 and is anticipated to reach US$ 4158 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Conjunctivitis was estimated to be worth US$ 3727 million in 2025 and is projected to reach US$ 4158 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 3950.00 (Single User License)Global Conjunctivitis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Conjunctivitis market is projected to grow from US$ 3674 million in 2024 to US$ 4099 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 133
USD 4900.00 (Single User License)Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Conjunctivitis was estimated to be worth US$ 3674 million and is forecast to reach approximately US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 132
USD 5900.00 (Single User License)Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Conjunctivitis market size was US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 76
USD 4250.00 (Single User License)Global Conjunctivitis Market Research Report 2025
The global market for Conjunctivitis was valued at US$ 3674 million in the year 2024 and is projected to reach a revised size of US$ 4099 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published: 2025-01-16
Pages: 82
USD 2900.00 (Single User License)Global Conjunctivitis Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-16
Pages: 125
USD 5900.00 (Single User License)Global Conjunctivitis Market Insights, Forecast to 2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-07
Pages: 95
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now